1982
DOI: 10.1620/tjem.137.191
|View full text |Cite
|
Sign up to set email alerts
|

ACTH content in the anterior pituitary after the infusion of various doses of corticosterone and dexamethasone in normal and adrenalectomized rats.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

1987
1987
2019
2019

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(7 citation statements)
references
References 9 publications
0
7
0
Order By: Relevance
“…This is an important finding because it implies that the alteration we observed in hypothalamic ACTH was specific and not due to a generalized effect of dexamethasone to increase neuronal content of hypotha lamic neuropeptides. Previous studies have reported an in crease [2], decrease [15,24], or no change [33] in hypotha lamic CRH content with dexamethasone. Methodologic differences in these studies make valid comparison diffi cult.…”
Section: Discussionmentioning
confidence: 82%
See 2 more Smart Citations
“…This is an important finding because it implies that the alteration we observed in hypothalamic ACTH was specific and not due to a generalized effect of dexamethasone to increase neuronal content of hypotha lamic neuropeptides. Previous studies have reported an in crease [2], decrease [15,24], or no change [33] in hypotha lamic CRH content with dexamethasone. Methodologic differences in these studies make valid comparison diffi cult.…”
Section: Discussionmentioning
confidence: 82%
“…Although tissue content studies may be difficult to interpret due to the dynamic relationship be tween synthesis and release, the present findings of in creased hypothalamic tissue ACTH content coupled with decreased CSF ACTH suggest that dexamethasone inhibits release of immunoreactive ACTH from hypothalamic AC'TH-containing neurons. Dexamethasone has previously been shown to inhibit release of ACTH from the anterior pituitary corticotroph both in vitro [4,9,30] and in vivo [24]. While its effect on peripheral ACTH release is primarily at the level of the pituitary [23], dexamethasone does cross the blood-brain barrier and can bind to specific steroid binding sites in the brain [3,23].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…An increase in FKBP51, induced by GC via an ultra-short feedback loop, reduces sensitivity and in turn nuclear translocation of the receptor (for review see [29]). At the level of the pituitary, GC exert their negative feedback function by repressing the gene encoding for pro-opiomelanocortin (POMC), the precursor of ACTH [30], by directly inhibiting the release of ACTH vesicles into the periphery [31], [32] or by reducing CRH-R1 binding [33].…”
Section: Introductionmentioning
confidence: 99%
“…Upon disruption of cortisol synthesis, cortisol concentrations diminish slowly (τ ∼ 1hr) CRH concentrations rises abruptly (and probably in stages) after more than 1 hour of delay [5]; while the authors suggest a rate-sensitive feedback, the observed profiles suggest that a threshold (and probably multiple threshold) mechanism, relative to a set point, is more plausible. Constant infusion of a relatively small dose of 20 micrograms dexamethasone (DEX) did not reduce the hypothalamic CRF content; in contrast, the infusion of 202 and 504 micrograms DEX over 6 hr significantly reduced the hypothalamic CRF content [142]. These two evidences suggest a threshold mechanism for CRH synthesis regulation by GC.…”
Section: Ppvn-crhmentioning
confidence: 94%